Poly-Analyte Cancer Test
PACT is a poly-analyte diagnostic platform that combines biosensing and artificial intelligence. The biosensor measures the expression of proteins and microRNAs in peripheral blood without the requirements of amplification or sequencing. Then, a proprietary algorithm analyzes the expression of the biomarkers to deliver the diagnostic. This combination results in an accurate biomarker selection and an easy to use detection method providing a unique diagnostic test for seven types of cancer. After the FDA approval, the PACT platform will be sold to hospitals, clinics, and laboratories. PACT Platform can detect many pre-assembled panels of biomarkers, opening possibilities for secondary diagnostic solutions.